High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1720-8386
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII ; day:9 ; month:6 ; year:2018 ; pages:1-9
Journal of endocrinological investigation ; (9.6.2018), 1-9
- Creator
-
Miśkiewicz, P.
- Contributor
-
Milczarek-Banach, J.
Rutkowska-Hinc, B.
Kondracka, A.
Bednarczuk, T.
SpringerLink (Online service)
- DOI
-
10.1007/s40618-018-0907-z
- URN
-
urn:nbn:de:101:1-2018081523505463814502
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Miśkiewicz, P.
- Milczarek-Banach, J.
- Rutkowska-Hinc, B.
- Kondracka, A.
- Bednarczuk, T.
- SpringerLink (Online service)
Other Objects (12)
High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19
Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy
Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review
Short-term outcome of intravenous methylprednisolone pulse therapy versus oral prednisolone in patients with epileptic spasms
Post-infectious new daily persistent headache may respond to intravenous methylprednisolone
Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
High-dose intravenous glucocorticoid induces hyperamylasemia: a case series
High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19
Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy
Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review
Short-term outcome of intravenous methylprednisolone pulse therapy versus oral prednisolone in patients with epileptic spasms
Post-infectious new daily persistent headache may respond to intravenous methylprednisolone
Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
High-dose intravenous glucocorticoid induces hyperamylasemia: a case series
High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19
Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy
Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review
Short-term outcome of intravenous methylprednisolone pulse therapy versus oral prednisolone in patients with epileptic spasms
Post-infectious new daily persistent headache may respond to intravenous methylprednisolone
Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer